Aaron M. Wenger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aaron M. Wenger has a total of 537 co-authors. Here are the top co-authors by number of shared publications:
- Justin M. Zook
Material Measurement Laboratory, National Institute of Standards and Technology, Gaithersburg, USA
11 shared publications - Fritz Joachim Sedlazeck
Baylor College of Medicine
9 shared publications - Nathanael D. Olson
National Institute of Standards and Technology, Material Measurement Laboratory, 100 Bureau Dr., Gaithersburg, MD 20899, USA
9 shared publications - William J. Rowell
PacBio
7 shared publications - Chunlin Xiao
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 45 Center Drive, Bethesda, MD 20894, USA
6 shared publications - Jennifer McDaniel
Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Dr., Gaithersburg, USA
6 shared publications
Latest Publications
- Open Access
A near-complete human pancreatic cancer genome
Summary: Genomic changes are central to cancer, so sequencing is essential for understanding tumor evolution and advancing precision medicine, but resolving somatic variants and methylation is challenging in regions with repeats, reference gaps, and germline variants. 1–4 To identify the full spectrum of somatic variants, including complex rearrangements, we construct and curate near-complete, haplotype-resolved assemblies of the most recent common ancestor of an early-passage, broadly-consented hypodiploid pancreatic cancer cell line and matched normal tissues. 5 The tumor assembly recapitulates all 35 chromosomes observed by karyotyping, including translocation-induced hybrid chromosomes containing dynamic dicentric and fused centromeres, nested foldback inversions causing 14 breakpoints with a haplotype switch in a single derivative chromosome, and centromeric satellite tandem duplications up to 136 kbp. Our tumor-normal assembly-based benchmark expands previous multi-technology ensemble benchmark approaches, adding >8,000 somatic small variants altering ∼40 kbp and 149 somatic SVs altering 939 kbp, including 2,764 small variants and 126 SVs not represented on GRCh38. Additionally, 5,111 somatic small variants change representation because they alter germline variants on GRCh38, impacting mutational signatures. Most source-resolved somatic LINE insertions originate from two non-reference germline LINE insertions with accessible promoter elements. These assemblies demonstrate that centromeric, acrocentric, telomeric, and other polymorphic regions, conventionally excluded from analysis, harbor extensive somatic and epigenetic changes and provide curated paired tumor-normal benchmarks to advance algorithms for repetitive regions of cancer genomes.
Open AccessA near-complete human pancreatic cancer genome
Summary: Genomic changes are central to cancer, so sequencing is essential for understanding tumor evolution and advancing precision medicine, but resolving somatic variants and methylation is challenging in regions with repeats, reference gaps, and germline variants. 1–4 To identify the full spectrum of somatic variants, including complex rearrangements, we construct and curate near-complete, haplotype-resolved assemblies of the most recent common ancestor of an early-passage, broadly-consented hypodiploid pancreatic cancer cell line and matched normal tissues. 5 The tumor assembly recapitulates all 35 chromosomes observed by karyotyping, including translocation-induced hybrid chromosomes containing dynamic dicentric and fused centromeres, nested foldback inversions causing 14 breakpoints with a haplotype switch in a single derivative chromosome, and centromeric satellite tandem duplications up to 136 kbp. Our tumor-normal assembly-based benchmark expands previous multi-technology ensemble benchmark approaches, adding >8,000 somatic small variants altering ∼40 kbp and 149 somatic SVs altering 939 kbp, including 2,764 small variants and 126 SVs not represented on GRCh38. Additionally, 5,111 somatic small variants change representation because they alter germline variants on GRCh38, impacting mutational signatures. Most source-resolved somatic LINE insertions originate from two non-reference germline LINE insertions with accessible promoter elements. These assemblies demonstrate that centromeric, acrocentric, telomeric, and other polymorphic regions, conventionally excluded from analysis, harbor extensive somatic and epigenetic changes and provide curated paired tumor-normal benchmarks to advance algorithms for repetitive regions of cancer genomes.
- Open Access
- 8 August 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1385
Correction: Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
- 8 August 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1385
Open AccessCorrection: Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
- Open Access
- 16 July 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-22
Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line and matched normal cells from duodenal and pancreatic tissues. Data for the tumor-normal matched samples comes from seventeen distinct state-of-the-art whole genome measurement technologies, including high depth short and long-read bulk whole genome sequencing (WGS), single cell WGS, Hi-C, and karyotyping. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic variants. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.
- 16 July 2025
- Published by Springer Nature in Scientific Data
- Vol. 12 (1) , 1-22
Open AccessDevelopment and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line and matched normal cells from duodenal and pancreatic tissues. Data for the tumor-normal matched samples comes from seventeen distinct state-of-the-art whole genome measurement technologies, including high depth short and long-read bulk whole genome sequencing (WGS), single cell WGS, Hi-C, and karyotyping. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic variants. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.
- Open Access
Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first to be explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line (HG008-T) and matched normal cells from duodenal tissue (HG008-N-D) and pancreatic tissue (HG008-N-P). The data come from thirteen whole genome measurement technologies: Illumina paired-end, Element standard and long insert, Ultima UG100, PacBio (HiFi and Onso), Oxford Nanopore (standard and ultra-long), Bionano Optical Mapping, Arima and Phase Genomics Hi-C, G-banded karyotyping, directional genomic hybridization, and BioSkryb Genomics single-cell ResolveDNA. Most tumor data is from a large homogenous batch of non-viable cells after 23 passages of the primary tumor cells, along with some data from different passages to enable an initial understanding of genomic instability. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. In addition, extensive data from two different normal tissues from the same individual can enable understanding of mosaicism. Long reads also contain methylation tags for epigenetic analyses. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic mutations. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.
Open AccessDevelopment and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair
The Genome in a Bottle Consortium (GIAB), hosted by the National Institute of Standards and Technology (NIST), is developing new matched tumor-normal samples, the first to be explicitly consented for public dissemination of genomic data and cell lines. Here, we describe a comprehensive genomic dataset from the first individual, HG008, including DNA from an adherent, epithelial-like pancreatic ductal adenocarcinoma (PDAC) tumor cell line (HG008-T) and matched normal cells from duodenal tissue (HG008-N-D) and pancreatic tissue (HG008-N-P). The data come from thirteen whole genome measurement technologies: Illumina paired-end, Element standard and long insert, Ultima UG100, PacBio (HiFi and Onso), Oxford Nanopore (standard and ultra-long), Bionano Optical Mapping, Arima and Phase Genomics Hi-C, G-banded karyotyping, directional genomic hybridization, and BioSkryb Genomics single-cell ResolveDNA. Most tumor data is from a large homogenous batch of non-viable cells after 23 passages of the primary tumor cells, along with some data from different passages to enable an initial understanding of genomic instability. These data will be used by the GIAB Consortium to develop matched tumor-normal benchmarks for somatic variant detection. In addition, extensive data from two different normal tissues from the same individual can enable understanding of mosaicism. Long reads also contain methylation tags for epigenetic analyses. We expect these data to facilitate innovation for whole genome measurement technologies, de novo assembly of tumor and normal genomes, and bioinformatic tools to identify small and structural somatic mutations. This first-of-its-kind broadly consented open-access resource will facilitate further understanding of sequencing methods used for cancer biology.
- Open Access
- 25 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (2)
HiPhase: jointly phasing small, structural, and tandem repeat variants from HiFi sequencing
Motivation: In diploid organisms, phasing is the problem of assigning the alleles at heterozygous variants to one of two haplotypes. Reads from PacBio HiFi sequencing provide long, accurate observations that can be used as the basis for both calling and phasing variants. HiFi reads also excel at calling larger classes of variation, such as structural or tandem repeat variants. However, current phasing tools typically only phase small variants, leaving larger variants unphased. Results: We developed HiPhase, a tool that jointly phases SNVs, indels, structural, and tandem repeat variants. The main benefits of HiPhase are (i) dual mode allele assignment for detecting large variants, (ii) a novel application of the A*-algorithm to phasing, and (iii) logic allowing phase blocks to span breaks caused by alignment issues around reference gaps and homozygous deletions. In our assessment, HiPhase produced an average phase block NG50 of 480 kb with 929 switchflip errors and fully phased 93.8% of genes, improving over the current state of the art. Additionally, HiPhase jointly phases SNVs, indels, structural, and tandem repeat variants and includes innate multi-threading, statistics gathering, and concurrent phased alignment output generation. Availability and implementation: HiPhase is available as source code and a pre-compiled Linux binary with a user guide at https://github.com/PacificBiosciences/HiPhase.
- 25 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40 (2)
Open AccessHiPhase: jointly phasing small, structural, and tandem repeat variants from HiFi sequencing
Motivation: In diploid organisms, phasing is the problem of assigning the alleles at heterozygous variants to one of two haplotypes. Reads from PacBio HiFi sequencing provide long, accurate observations that can be used as the basis for both calling and phasing variants. HiFi reads also excel at calling larger classes of variation, such as structural or tandem repeat variants. However, current phasing tools typically only phase small variants, leaving larger variants unphased. Results: We developed HiPhase, a tool that jointly phases SNVs, indels, structural, and tandem repeat variants. The main benefits of HiPhase are (i) dual mode allele assignment for detecting large variants, (ii) a novel application of the A*-algorithm to phasing, and (iii) logic allowing phase blocks to span breaks caused by alignment issues around reference gaps and homozygous deletions. In our assessment, HiPhase produced an average phase block NG50 of 480 kb with 929 switchflip errors and fully phased 93.8% of genes, improving over the current state of the art. Additionally, HiPhase jointly phases SNVs, indels, structural, and tandem repeat variants and includes innate multi-threading, statistics gathering, and concurrent phased alignment output generation. Availability and implementation: HiPhase is available as source code and a pre-compiled Linux binary with a user guide at https://github.com/PacificBiosciences/HiPhase.
- Open Access
Resolving the unsolved: Comprehensive assessment of tandem repeats at scale
Tandem repeat (TR) variation is associated with gene expression changes and over 50 rare monogenic diseases. Recent advances in sequencing have enabled accurate, long reads that can characterize the full-length sequence and methylation profile of TRs. However, despite these advances in sequencing technology, computational methods to fully profile tandem repeats across the genome do not exist. To address this gap, we introduce tools for tandem repeat genotyping (TRGT), visualization and an accompanying TR database. TRGT accurately resolves the length and sequence composition of TR regions in the human genome. Assessing 937,122 TRs, TRGT showed a Mendelian concordance of 99.56%, allowing a single repeat unit difference. In six samples with known repeat expansions, TRGT detected all repeat expansions while also identifying methylation signals, mosaicism, and providing finer resolution of repeat length. Additionally, we release a database with allele sequences and methylation levels for 937,122 TRs across 100 genomes.
Open AccessResolving the unsolved: Comprehensive assessment of tandem repeats at scale
Tandem repeat (TR) variation is associated with gene expression changes and over 50 rare monogenic diseases. Recent advances in sequencing have enabled accurate, long reads that can characterize the full-length sequence and methylation profile of TRs. However, despite these advances in sequencing technology, computational methods to fully profile tandem repeats across the genome do not exist. To address this gap, we introduce tools for tandem repeat genotyping (TRGT), visualization and an accompanying TR database. TRGT accurately resolves the length and sequence composition of TR regions in the human genome. Assessing 937,122 TRs, TRGT showed a Mendelian concordance of 99.56%, allowing a single repeat unit difference. In six samples with known repeat expansions, TRGT detected all repeat expansions while also identifying methylation signals, mosaicism, and providing finer resolution of repeat length. Additionally, we release a database with allele sequences and methylation levels for 937,122 TRs across 100 genomes.
- Open Access
HiPhase: Jointly phasing small and structural variants from HiFi sequencing
Background In diploid organisms, phasing is the problem of assigning the heterozygous variants to one of two haplotypes. Reads from PacBio HiFi sequencing provide long, accurate observations that can be used as the basis for both calling and phasing variants. HiFi reads also excel at calling larger classes of variation such as structural variants. However, current phasing tools typically only phase small variants, leaving larger structural variants unphased. Methods We developed HiPhase, a tool that jointly phases SNVs, indels, and structural variants. The main benefits of HiPhase are 1) dual mode allele assignment for detecting structural variants, 2) a novel application of the A*-algorithm to phasing, and 3) logic allowing phase blocks to span breaks caused by alignment issues around reference gaps and homozygous deletions. Results In our assessment, HiPhase produced an average phase block NG50 of 493 kb with 933 switchflip errors and fully phased 95.2% of genes, improving over the current state of the art. Additionally, HiPhase jointly phases SNVs, indels, and structural variants and includes innate multi-threading, statistics gathering, and concurrent phased alignment output generation. Availability https://github.com/PacificBiosciences/HiPhase
Open AccessHiPhase: Jointly phasing small and structural variants from HiFi sequencing
Background In diploid organisms, phasing is the problem of assigning the heterozygous variants to one of two haplotypes. Reads from PacBio HiFi sequencing provide long, accurate observations that can be used as the basis for both calling and phasing variants. HiFi reads also excel at calling larger classes of variation such as structural variants. However, current phasing tools typically only phase small variants, leaving larger structural variants unphased. Methods We developed HiPhase, a tool that jointly phases SNVs, indels, and structural variants. The main benefits of HiPhase are 1) dual mode allele assignment for detecting structural variants, 2) a novel application of the A*-algorithm to phasing, and 3) logic allowing phase blocks to span breaks caused by alignment issues around reference gaps and homozygous deletions. Results In our assessment, HiPhase produced an average phase block NG50 of 493 kb with 933 switchflip errors and fully phased 95.2% of genes, improving over the current state of the art. Additionally, HiPhase jointly phases SNVs, indels, and structural variants and includes innate multi-threading, statistics gathering, and concurrent phased alignment output generation. Availability https://github.com/PacificBiosciences/HiPhase
- Open Access
The complete sequence of a human Y chromosome
The human Y chromosome has been notoriously difficult to sequence and assemble because of its complex repeat structure including long palindromes, tandem repeats, and segmental duplications 1–3 . As a result, more than half of the Y chromosome is missing from the GRCh38 reference sequence and it remains the last human chromosome to be finished 4, 5 . Here, the Telomere-to-Telomere (T2T) consortium presents the complete 62,460,029 base pair sequence of a human Y chromosome from the HG002 genome (T2T-Y) that corrects multiple errors in GRCh38-Y and adds over 30 million base pairs of sequence to the reference, revealing the complete ampliconic structures of TSPY , DAZ , and RBMY gene families; 41 additional protein-coding genes, mostly from the TSPY family; and an alternating pattern of human satellite 1 and 3 blocks in the heterochromatic Yq12 region. We have combined T2T-Y with a prior assembly of the CHM13 genome 4 and mapped available population variation, clinical variants, and functional genomics data to produce a complete and comprehensive reference sequence for all 24 human chromosomes.
Open AccessThe complete sequence of a human Y chromosome
The human Y chromosome has been notoriously difficult to sequence and assemble because of its complex repeat structure including long palindromes, tandem repeats, and segmental duplications 1–3 . As a result, more than half of the Y chromosome is missing from the GRCh38 reference sequence and it remains the last human chromosome to be finished 4, 5 . Here, the Telomere-to-Telomere (T2T) consortium presents the complete 62,460,029 base pair sequence of a human Y chromosome from the HG002 genome (T2T-Y) that corrects multiple errors in GRCh38-Y and adds over 30 million base pairs of sequence to the reference, revealing the complete ampliconic structures of TSPY , DAZ , and RBMY gene families; 41 additional protein-coding genes, mostly from the TSPY family; and an alternating pattern of human satellite 1 and 3 blocks in the heterochromatic Yq12 region. We have combined T2T-Y with a prior assembly of the CHM13 genome 4 and mapped available population variation, clinical variants, and functional genomics data to produce a complete and comprehensive reference sequence for all 24 human chromosomes.
- Open Access
- 8 June 2022
- Published by Elsevier in Cell Genomics
- Vol. 2 (6) , 100139
A multi-platform reference for somatic structural variation detection
- 8 June 2022
- Published by Elsevier in Cell Genomics
- Vol. 2 (6) , 100139
Open AccessA multi-platform reference for somatic structural variation detection
- Open Access
Sentieon DNAscope LongRead – A highly Accurate, Fast, and Efficient Pipeline for Germline Variant Calling from PacBio HiFi reads
PacBio ® HiFi sequencing is the first technology to offer economical and highly accurate long-read sequencing, with average read lengths greater than 10kb and average base accuracy of 99.8% 1 . Here, we present DNAscope LongRead, an accurate and efficient pipeline for germline variant calling from PacBio ® HiFi reads. DNAscope LongRead is a modification and extension of Sentieon’s DNAscope tool, a precisionFDA award-winning variant caller. DNAscope LongRead is computationally efficient, calling variants from 30x HiFi samples in under 4 hours on a 16-core machine (120 virtual core-hours) and highly accurate, with precision and recall on the most recent GIAB benchmark dataset exceeding 99.83% for HiFi samples sequenced at 30x coverage, and robust to changes in benchmark dataset and upstream library preparation and sequencing.
Open AccessSentieon DNAscope LongRead – A highly Accurate, Fast, and Efficient Pipeline for Germline Variant Calling from PacBio HiFi reads
PacBio ® HiFi sequencing is the first technology to offer economical and highly accurate long-read sequencing, with average read lengths greater than 10kb and average base accuracy of 99.8% 1 . Here, we present DNAscope LongRead, an accurate and efficient pipeline for germline variant calling from PacBio ® HiFi reads. DNAscope LongRead is a modification and extension of Sentieon’s DNAscope tool, a precisionFDA award-winning variant caller. DNAscope LongRead is computationally efficient, calling variants from 30x HiFi samples in under 4 hours on a 16-core machine (120 virtual core-hours) and highly accurate, with precision and recall on the most recent GIAB benchmark dataset exceeding 99.83% for HiFi samples sequenced at 30x coverage, and robust to changes in benchmark dataset and upstream library preparation and sequencing.